A
Alodokter
Providing an integrated mobile solution for patients and doctors
About Alodokter
Alodokter is a digital health platform operating in Indonesia, established in 2014 by Nathanael Faibis and Suci Arumsari. Faibis, who serves as CEO, previously worked at Lazada and Rocket Internet, bringing e-commerce and startup scaling experience to the healthcare sector. The company was founded to address the challenge of making high-quality healthcare more accessible and affordable in a country with a low doctor-to-patient ratio.
The firm's core business revolves around a comprehensive mobile application and website that serves over 30 million monthly active users. Alodokter provides an end-to-end solution for patients, beginning with a vast library of medical articles and information. Its primary service is telemedicine, allowing users to chat with general practitioners and specialists for consultations. The platform facilitates the booking of in-person appointments with a network of over 43,000 doctors across 1,500 hospitals and clinics. Additionally, the company offers an e-pharmacy service for purchasing prescribed medications and health insurance packages.
Alodokter's business model generates revenue from multiple streams. A significant portion comes from web advertising and telemedicine services, which are offered on both a subscription and a one-time fee basis. The company also earns income from commissions on patient referrals to hospitals and through its e-pharmacy and insurance product offerings. The platform has demonstrated a strong growth trajectory, backed by significant investor funding. It has raised a total of $49.7 million over nine funding rounds, including a $33 million Series C in 2019 led by Sequis. Notable investors include MDI Ventures, Golden Gate Ventures, Softbank Ventures Asia, and Samsung Ventures.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2014
- Headquarters
- Jakarta, Indonesia
- Employees
- 504
- Open positions
- None listed
- Dealroom signal
- 67.8/100
- Industry
- Health
- Sub-industry
- Health Platform
- Sector
- Health Tech & Medtech, Diabetes, Patient Care, Telemedicine, Tech for Patients, Insurtech Related, Hard Tech
- Technology
- Mobile app
- Business model
- Marketplace & ecommerce
- Client focus
- b2b, b2c
- Investment activity
- 1 company, latest Jul 2023
- Capital deployed
- —
- Preferred round
- ACQUISITION
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES COther financing | Feb 2024 | $5.2M | $136M | SBVA · Beacon Venture Capital · Sequis · Golden Gate Ventures | ↗ |
| LATE VCOther financing | Jul 2023 | $6M | $24M | Marubeni | ↗ |
Growth signals
Latest recorded traffic for Alodokter is 23M monthly website visits, down 8% over the last three months. Alodokter's team declined 1.9% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed4 investors entered at this stage
Pegasus Tech Ventures
Lim Der Shing
Golden Gate Ventures
500 Global
Series A1 investor entered at this stage
Series B and later8 investors entered at this stage
Sequis
MDI Ventures
Hera Capital
Heritas Capital Management
Samsung Ventures
Marubeni
Beacon Venture Capital
HL Mando Aftermarket
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Alodokter on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Alodokter’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









